SEARCH

SEARCH BY CITATION

References

  • ABADJI, V., LUCAS-LENARD, J.M., CHIN, C. & KENDALL, D.A. (1999). Involvement of the carboxyl terminus of the third intracellular loop of the CB1 receptor in constitutive activation of Gs. J. Neurochem., 72, 20322038.
  • ALVAREZ, R. & DANIELS, D.V. (1992). A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic-AMP phosphodiesterase using tritium-labeled substrates. Anal. Biochem., 203, 7682.
  • BARANN, M., MOLDERINGS, G., BRUSS, M., BONISCH, H., URBAN, B.W. & GOTHERT, M. (2002). Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br. J. Pharmacol., 137, 589596.
  • BECKETT, S.R.G., MILLNS, P.J. & KENDALL, D.A. (1999). The effect of cannabinoid ligands on [35S]GTPγS binding in the rat brain. Br. J. Pharmacol., 128, 192P.
  • BISOGNO, T., SEPE, N., DE PETROCELLIS, L., MECHOULAM, R. & DI MARZO, V. (1997). The sleep inducing factor oleamide is produced by mouse neuroblastoma cells. Biochem. Biophys. Res. Commun., 239, 473479.
  • BOGER, D.L., FECIK, R.A., PATTERSON, J.E., MIYAUCHI, H., PATRICELLI, M.P. & CRAVATT, B.F. (2000a). Fatty acid amide hydrolase substrate specificity. Bioorg. Med. Chem. Lett., 10, 26132616.
  • BOGER, D.L., HENRIKSEN, S.J. & CRAVATT, B.F. (1998). Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signalling molecules. Curr. Pharm. Design, 4, 303314.
  • BOGER, D.L., SATO, H., LERNER, A.E., GUAN, X. & GILULA, N.B. (1999). Arachidonic acid amide inhibitors of gap junction cell-cell communication. Bioorg. Med. Chem. Lett., 9, 11511154.
  • BOGER, D.L., SATO, H., LERNER, A.E., HEDRICK, M.P., FECIK, R.A., MIYAUCHI, H., WILKIE, G.D., AUSTIN, B.J., PATRICELLI, M.P. & CRAVATT, B.F. (2000b). Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. U.S.A., 97, 50445049.
  • BORING, D.L., BERGLUND, B.A. & HOWLETT, A.C. (1996). Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors. Prostaglandins Leukot. Essent. Fatty Acids, 55, 207210.
  • BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248254.
  • BREIVOGEL, C.S., GRIFFIN, G., DI MARZO, V. & MARTIN, B.R. (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155163.
  • CHEER, J.F., CADOGAN, A.K., MARSDEN, C.A., FONE, K.C.F. & KENDALL, D.A. (1999). Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology, 38, 533541.
  • CHIN, C.N., MURPHY, J.W., HUFFMAN, J.W. & KENDALL, D.A. (1999). The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, the peripheral cannabinoid receptor. J. Pharmacol. Exp. Ther., 29, 837844.
  • COYNE, L., LEES, G., NICHOLSON, R.A., ZHENG, J. & NEUFIELD, K.D. (2002). The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro. Br. J. Pharmacol., 135, 19771987.
  • CRAVATT, B.F., PROSPERO-GARCIA, O., SIUZDAK, G., GILULA, N.B., HENRIKSEN, S.J., BOGER, D.L. & LERNER, R.A. (1995). Chemical characterization of a family of brain lipids that induce sleep. Science, 268, 15061509.
  • DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 19461949.
  • DI MARZO, V. (1998). Endocannabinoids and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta, 1392, 153175.
  • DI MARZO, V., BREIVOGEL, C.S., TAO, Q., BRIDGEN, D.T., RAZDAN, R.K., ZIMMER, A.M., ZIMMER, A. & MARTIN, B.R. (2000). Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem., 75, 24342444.
  • DOUGALIS, A., LEES, G. & GANELLIN, R.C. (2004). The sleep inducing brain lipid cis-oleamide (cOA) does not modulate serotonergic transmission in the CA1 pyramidal neurons of the hippocampus in vitro. Neuropharmacol, 46, 6373.
  • FEDOROVA, I., HASHIMOTO, A., FECIK, R.A., HEDRICK, M.P., HANUS, L.O., BOGER, D.L., RICE, K.C. & BASILE, A.S. (2001). Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J. Pharmacol. Exp. Ther., 299, 332342.
  • FELDER, C.C., JOYCE, K.E., BRILEY, E.M., GLASS, M., MACKIE, K.P., FAHEY, K.J., CULLINAN, G.J., HUNDEN, D.C., JOHNSON, D.W., CHANEY, M.O., KOPPEL, G.A. & BROWNSTEIN, M. (1998). LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J. Pharmacol. Exp. Ther., 284, 291297.
  • FELDER, C.C., JOYCE, K.E., BRILEY, E.M., MANSOURI, J., MACKIE, K., BLOND, O., LAI, Y., MA, A.L. & MITCHELL, R.L. (1995). Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol., 48, 443450.
  • GLASS, M. & FELDER, C.C. (1997). Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci., 17, 53275333.
  • GRIFFIN, G., ATKINSON, P.J., SHOWALTER, V.M., MARTIN, B.R. & ABOOD, M.E. (1998). Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5′-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. J. Pharmacol. Exp. Ther., 285, 553560.
  • HEDLUND, P.B., CARSON, M.J., SUTCLIFFE, J.G. & THOMAS, E.A. (1999). Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors. Biochem. Pharmacol., 58, 18071813.
  • HILLARD, C.J., EDGEMOND, W.S. & CAMPBELL, W.B. (1995). Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. J. Neurochem., 64, 677683.
  • HUIDOBRO-TORO, J.P. & HARRIS, R.A. (1996). Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors. Proc. Natl. Acad. Sci. U.S.A., 93, 80788082.
  • HUITRON-RESENDIZ, S., GOMBART, L., CRAVATT, B.F. & HENRIKSEN, S.J. (2001). Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp. Neurol., 172, 235243.
  • IWAMURA, H., SUZUKI, H., UEDA, Y., KAYA, T. & INABA, T. (2001). In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J. Pharmacol. Exp. Ther., 296, 420425.
  • LAMBERT, D.M. & DI MARZO, V. (1999). The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic Curr. Med. Chem., 6, 757773.
  • LAPOSKY, A.D., HOMANICS, G.E., BASILE, A. & MENDELSON, W.B. (2001). Deletion of the GABAA receptor β3 subunit eliminates the hypnotic actions of oleamide in mice. NeuroReport, 12, 41434147.
  • LEGGETT, J.D., OVERBURY, A.L., BECKETT, S.R.G. & KENDALL, D.A. (2002). Oleamide stimulates [35S]GTPγS binding in rat brain preparations via a cannabinoid receptor. Br. J. Pharmacol., 137, 114P.
  • LICHTMAN, A.H., HAWKINS, E.G., GRIFFIN, G. & CRAVATT, B.F. (2002). Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J. Pharmacol. Exp. Ther., 302, 7379.
  • MANG, C.F., ERBELDING, D. & KILBINGER, H. (2001). Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Br. J. Pharmacol., 134, 161167.
  • MECHOULAM, R. & FRIDE, E. (1995). The unpaved road to the endogenous brain cannabinoid ligands, the anandamides. In Cannabinoid Receptors. ed. Pertwee, R.G. pp. 233258 Academic Press, London.
  • MECHOULAM, R., FRIDE, E., HANUS, L., SHESKIN, T., BISOGNO, T., DI MARZO, V., BAYEWITCH, M. & VOGEL, Z. (1997). Anandamide may mediate sleep induction. Nature, 389, 2526.
  • MENDELSON, W.B. & BASILE, A.S. (1999). The hypnotic actions of oleamide are blocked by a camabinoid receptor antagonist. NeuroReport, 10, 32373239.
  • MURILLO-RODRIGUEZ, E., SANCHEZ-ALAVEZ, M., NAVARRO, L., MARTINEZ-GONZALEZ, D., DRUCKER-COLIN, R. & PROSPERO-GARCIA, O. (1998). Anandamide modulates sleep and memory in rats. Brain Res., 812, 270274.
  • MURILLO-RODRIGUEZ, E., GIORDANO, M., CABEZA, R., HENRIKSEN, S.J., DIAZ, M.M., NAVARRO, L. & PROSPERO-GARCIA, O. (2001). Oleamide modulates memory in rats. Neurosci. Lett., 313, 6164.
  • PERTWEE, R.G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther., 74, 129180.
  • PERTWEE, R.G. & ROSS, R.A. (2002). Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids, 66, 101121.
  • PETITET, F., MARIN, L. & DOBLE, A. (1996). Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A. Neuroreport, 7, 789792.
  • RALEVIC, V., KENDALL, D.A., BENNETT, T. & GARDINER, S.M. (2000). Comparison of the effects of anandamide and methanandamide in bioassays. Br. J. Pharmacol., 129, 141P.
  • RINALDI-CARMONA, M., PIALOT, F., CONGY, C., REDON, E., BARTH, F., BACHY, A., BRELIERE, J.C., SOUBRIE, P. & LE FUR, G. (1996). Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci., 58, 12391247.
  • SHESKIN, T., HANUS, L., SLAGER, J., VOGEL, Z. & MECHOULAM, R. (1997). Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem., 40, 659667.
  • SONG, Z.H. & BONNER, T.I. (1996). A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. Mol. Pharmacol., 49, 891896.
  • SUGIURA, T., KONDO, S., KODAKA, T., TONEGAWA, T., NAKANE, S., YAMASHITA, A., ISHIMA, Y. & WAKU, K. (1996). Enzymatic synthesis of oleamide (cis-9, 10-octadecenoamide), sleep-inducing lipid, by rat brain microsomes. Biochem. Mol. Biol. Int., 40, 931938.
  • THOMAS, E.A., CARSON, M.J., NEAL, M.J. & SUTCLIFFE, J.G. (1997). Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. Proc. Natl. Acad. Sci. U.S.A., 94, 1411514119.
  • THOMAS, E.A., CRAVATT, B.F. & SUTCLIFFE, J.G. (1999). The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus. J. Neurochem., 72, 23702378.
  • WILEY, J.L. & MARTIN, B.R. (2002). Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. Chem. Phys. Lipids, 121, 5763.
  • YANG, J.Y., WU, C.F. & SONG, H.R. (1999). Studies on the sedative and hypnotic effects of oleamide in mice. Arzneimittelforschung, 49, 663667.
  • ZHOU, D. & SONG, Z.H. (2001). CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells. J. Neurosci. Res., 65, 346353.